Inhibition of the algesic effect of bradykinin and acetylcholine by mepacrine
Identifieur interne : 003960 ( Main/Exploration ); précédent : 003959; suivant : 003961Inhibition of the algesic effect of bradykinin and acetylcholine by mepacrine
Auteurs : H. Juan [Autriche]Source :
- Naunyn-Schmiedeberg's Archives of Pharmacology [ 0028-1298 ] ; 1977-12-01.
English descriptors
- KwdEn :
- Teeft :
Abstract
Summary: 1. The isolated perfused rabbit ear connected to the body by its nerve only was used to investigate the influence of mepacrine on the algesic effect of bradykinin and acetylcholine. For comparison, quinidine was included in this investigation. 2. Infusion of mepacrine or quinidine (2–10 μg/ml) into the rabbit ear reduces the algesic effect of bradykinin as well as of acetylcholine in proportion to the dose. 3. Infusion of postglandin E1 (10 ng/ml) in addition to mepacrine or quinidine restores the inhibited algesic effect of bradykinin more than that of acetylcholine. 4. Mepacrine and quinidine (10 μg/ml) reduce the brief vasoconstriction elicited by bradykinin in the rabbit ear. 5. The results suggest that mepacrine or quinidine reduce the algesic effect of bradykinin primarily by inhibiting the release of E-type prostaglandins which sensitize pain receptors and secondarily by an unspecific antagonism (local-anaesthetic action). The effect of acetylcholine, however, appears to be reduced mainly by an unspecific antagonism.
Url:
DOI: 10.1007/BF00501260
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002875
- to stream Istex, to step Curation: 002875
- to stream Istex, to step Checkpoint: 002708
- to stream Main, to step Merge: 003A39
- to stream Main, to step Curation: 003960
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inhibition of the algesic effect of bradykinin and acetylcholine by mepacrine</title><author><name sortKey="Juan, H" sort="Juan, H" uniqKey="Juan H" first="H." last="Juan">H. Juan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:42EA151766DDC66D495F07698D731698792D4051</idno><date when="1977" year="1977">1977</date><idno type="doi">10.1007/BF00501260</idno><idno type="url">https://api.istex.fr/ark:/67375/1BB-X5DZ43VN-S/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002875</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002875</idno><idno type="wicri:Area/Istex/Curation">002875</idno><idno type="wicri:Area/Istex/Checkpoint">002708</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002708</idno><idno type="wicri:doubleKey">0028-1298:1977:Juan H:inhibition:of:the</idno><idno type="wicri:Area/Main/Merge">003A39</idno><idno type="wicri:Area/Main/Curation">003960</idno><idno type="wicri:Area/Main/Exploration">003960</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Inhibition of the algesic effect of bradykinin and acetylcholine by mepacrine</title><author><name sortKey="Juan, H" sort="Juan, H" uniqKey="Juan H" first="H." last="Juan">H. Juan</name><affiliation wicri:level="1"><country xml:lang="fr">Autriche</country><wicri:regionArea>Institut für Experimentelle und Klinische Pharmakologie der Universität Graz, Universitätsplatz 4, A-8010, Graz</wicri:regionArea><wicri:noRegion>Graz</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Naunyn-Schmiedeberg's Archives of Pharmacology</title><title level="j" type="abbrev">Naunyn-Schmiedeberg's Arch. Pharmacol.</title><idno type="ISSN">0028-1298</idno><idno type="eISSN">1432-1912</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="1977-12-01">1977-12-01</date><biblScope unit="volume">301</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="23">23</biblScope><biblScope unit="page" to="27">27</biblScope></imprint><idno type="ISSN">0028-1298</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0028-1298</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acetylcholine</term><term>Bradykinin</term><term>Mepacrine</term><term>Pain response</term><term>Prostaglandin E1</term><term>Quinidine</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Acetylcholine</term><term>Additional infusion</term><term>Algesic</term><term>Algesic effect</term><term>Blood pressure</term><term>Bradykinin</term><term>Ferreira</term><term>Indomethacin</term><term>Infusion</term><term>Lembeck</term><term>Mepacrine</term><term>Paravascular pain receptors</term><term>Perfused rabbit</term><term>Pge1</term><term>Pharmacol</term><term>Prostaglandin</term><term>Quinidine</term><term>Receptor</term><term>Reflex fall</term><term>Vane</term><term>Venous outflow</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary: 1. The isolated perfused rabbit ear connected to the body by its nerve only was used to investigate the influence of mepacrine on the algesic effect of bradykinin and acetylcholine. For comparison, quinidine was included in this investigation. 2. Infusion of mepacrine or quinidine (2–10 μg/ml) into the rabbit ear reduces the algesic effect of bradykinin as well as of acetylcholine in proportion to the dose. 3. Infusion of postglandin E1 (10 ng/ml) in addition to mepacrine or quinidine restores the inhibited algesic effect of bradykinin more than that of acetylcholine. 4. Mepacrine and quinidine (10 μg/ml) reduce the brief vasoconstriction elicited by bradykinin in the rabbit ear. 5. The results suggest that mepacrine or quinidine reduce the algesic effect of bradykinin primarily by inhibiting the release of E-type prostaglandins which sensitize pain receptors and secondarily by an unspecific antagonism (local-anaesthetic action). The effect of acetylcholine, however, appears to be reduced mainly by an unspecific antagonism.</div></front></TEI><affiliations><list><country><li>Autriche</li></country></list><tree><country name="Autriche"><noRegion><name sortKey="Juan, H" sort="Juan, H" uniqKey="Juan H" first="H." last="Juan">H. Juan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003960 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003960 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:42EA151766DDC66D495F07698D731698792D4051
|texte= Inhibition of the algesic effect of bradykinin and acetylcholine by mepacrine
}}
| This area was generated with Dilib version V0.6.33. |  |